— · —

ACAD (ACAD) Stock

$29.21 +2.67% —: ACAD —

Valuation

MetricValue
Price$29.21
Market Cap$5.00B
P/E Ratio8.94
P/B Ratio2.86
P/S Ratio3.20
EPS (TTM)$2.29
52-Week High$29.21
52-Week Low$14.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE31.87%
ROA25.00%
ROCE8.56%
Gross Margin9.79%
Operating Margin9.79%
Net Margin34.30%
Debt/Equity0.04
Current Ratio3.83

Annual Financials (USD)

Metric20212022202320242025
Revenue$484.0M$517.0M$726.0M$958.0M$1.1B
Operating Profit$-170.0M$-224.0M$-73.0M$231.0M$105.0M
Net Profit$-168.0M$-216.0M$-61.0M$226.0M$391.0M
EPS$-1.05$-1.34$-0.37$1.36$2.29
Op Margin-35.2%-43.2%-10.1%24.1%9.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$700.0M$588.0M$749.0M$1.2B$1.6B
Total Liabilities$159.0M$187.0M$317.0M$455.0M$337.0M
Cash$147.0M$115.0M$189.0M$320.0M$178.0M
Borrowings$64.0M$62.0M$57.0M$52.0M$52.0M

Latest News

Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026 Business Wire · Jul 15, 2026 An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors? Motley Fool · Jul 11, 2026 ACADIA Pharmaceuticals (ACAD) Names A New Chief People Officer, Is It Still Below Fair Value? Simply Wall St. · Jul 11, 2026 Is ACADIA Pharmaceuticals (ACAD) Still Undervalued After The Daybue Win? Simply Wall St. · Jul 10, 2026 How CHMP’s Positive Rett Syndrome Ruling on DAYBU Could Impact ACADIA Pharmaceuticals (ACAD) Investors Simply Wall St. · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-126.0M$-114.0M$17.0M$158.0M$110.0M
Investing Cash Flow$-72.0M$73.0M$-8.0M$-31.0M$-307.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-179.0M$-33.0M$74.0M$134.0M$-142.0M
Free Cash Flow$-127.0M$-114.0M$-23.0M$157.0M$105.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA32.20
FCF Yield6.06%
Quick Ratio3.48
Interest Coverage—
Return 1Y11.30%
Return 3Y-18.44%
Return 5Y17.05%

Ownership

Insiders Held0.32%
Institutions Held98.91%
Institutions Float Held99.23%
Institutional HolderSharesReport Date
Baker Bros. Advisors, LP42,896,6902026-03-31
Blackrock Inc.21,550,9212026-03-31
Vanguard Portfolio Management LLC8,671,6452026-03-31
State Street Corporation8,332,7712026-03-31
RTW Investments LP7,144,5242026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADMA $8.71 -0.91% 12.17 $2.02B 0.00%
BLTEBelite Bio, Inc $157.14 -2.45% -61.62 $6.30B 0.00%
CRNX $83.81 -0.09% -8.57 $8.87B 0.00%
DYN $25.97 +2.89% -6.05 $4.85B 0.00%
IMVT $39.24 +1.91% -11.09 $8.06B 0.00%

About ACAD

ACAD stock trades at $29.21 with a market capitalization of $5.00B. The stock is valued at a price-to-earnings (P/E) ratio of 8.94, price-to-book of 2.86, price-to-sales of 3.20. Over the past 52 weeks the stock has ranged between $14.08 and $29.21, and currently trades at its 52-week high.

On profitability, ACAD generates a return on equity (ROE) of 31.87% — well above the market average, a sign of a high-quality business, return on capital employed of 8.56%, an operating margin of 9.79%, a net profit margin of 34.30%.

Related — Stocks

BNY — $152.52 -2.54% CIEN — $412.39 +2.14% CBRS — $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY — $88.68 +0.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides